Increased Expression of Myeloid-Derived Suppressor Cells in Patients with HBV-Related Hepatocellular Carcinoma

Figure 1

Frequency of circulating MDSCs in study subjects. (a) Frequency of MDSCs, PMN-MDSCs, and M-MDSCs in HCC patients, CHB patients, and healthy controls. (b) Frequency of MDSCs, PMN-MDSCs, and M-MDSCs in HCC patients who received and did not receive anti-HBV therapy.